Capital One Financial assumed coverage on shares of Olema Pharmaceuticals (NASDAQ:OLMA – Get Rating) in a research report released on Friday morning, The Fly reports. The firm issued an overweight rating and a $16.00 target price on the stock. Several other brokerages also recently issued reports on OLMA. Credit Suisse Group reduced their price objective […]
Olema Pharmaceuticals (NASDAQ:OLMA – Get Rating)‘s stock had its “outperform” rating restated by research analysts at Lifesci Capital in a research note issued to investors on Wednesday, PriceTargets.com reports. Other equities analysts have also issued research reports about the company. Credit Suisse Group decreased their target price on Olema Pharmaceuticals from $12.00 to $11.00 and […]